Emergence of Integrase Resistance Mutations During Initial Therapy Containing Dolutegravir.

Fulcher, Jennifer A

Emergence of Integrase Resistance Mutations During Initial Therapy Containing Dolutegravir. [electronic resource] - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 08 2018 - 791-794 p. digital

Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural

1537-6591

10.1093/cid/ciy228 doi


Antiretroviral Therapy, Highly Active
Drug Resistance, Viral
Genotype
HIV Infections--drug therapy
HIV Integrase Inhibitors--therapeutic use
HIV-1--drug effects
Heterocyclic Compounds, 3-Ring--therapeutic use
Humans
Integrases--genetics
Male
Middle Aged
Mutation
Oxazines
Piperazines
Pyridones
Sequence Analysis, DNA
Treatment Failure